Facts About Right to Try

For terminal patients who have exhausted their conventional treatment options, obtaining access to potentially life-saving investigational medications is often extremely difficult. The patient can attempt to enroll in a clinical trial, but many of the sickest individuals do not qualify. In fact, only 3 percent of cancer patients today are enrolled in clinical trials. For […]

Read More

5 Reasons for Right to Try

1. Right To Try is needed because most terminal patients cannot participate in clinical trials. Fewer than three percent of all cancer patients can enroll in clinical trials, and for other diseases like ALS, it’s even lower. And for rare diseases like deadly Duchenne muscular dystrophy, it’s lower still. Patients who get into clinical trials […]

Read More

What is Right to Try

Right to Try is a law that protects the right of terminally ill patients to pursue treatments that have passed Phase 1 of the FDA approval process but are not yet on pharmacy shelves. In essence, Right To Try allows doctors to prescribe to terminally ill patients medicines being safely used in clinical trials. Fewer […]

Read More

Right to Try Fact vs. Fiction

Download the PDF here    Fictitious Claim Fact  Right to Try would cut the FDA out of the process Right to Try not only recognizes the FDA’s important and valued role in providing for patient safety, but it also works in tandem with the FDA human safety requirements, payment rules, and reporting requirements. Right to […]

Read More

Jim Burhorn

Jim Burhorn was a healthy 59-year-old man living in Colorado when he was diagnosed with neuroendocrine cancer. After removing part of his pancreas, Jim’s doctors recommended a promising treatment. But Jim would have to travel to Switzerland for the treatment because the FDA hasn’t yet approved it in the United States. Jim was afraid if […]

Read More

Mark Angelo

On his birthday and six months after spotting a lump on his left collarbone, Mark Angelo was diagnosed with pancreatic neuroendocrine cancer. Mark would spend the next three years undergoing oral chemotherapy treatment while his health and quality of life quickly declined. The chemo proved to be ineffective after exhausting all treatment options, Mark’s doctor […]

Read More

David Curtis Glebe

In the summer of 2013, Dr. David Curtis Glebe was diagnosed with Stage IV pancreatic neuroendocrine cancer, the same rare cancer that took the life of former Apple CEO Steve Jobs. After undergoing an aggressive regimen of oral chemotherapy for over two years, resulting in a remarkable 90% decrease in his tumor burden, Dr. Glebe’s […]

Read More

Jackson Silva

At only four weeks old Jackson’s parents noticed that he was showing signs of daily pain. At three months old, Jackson was diagnosed with the most severe form of spinal muscular atrophy. The Silvas were told there was nothing that could be done. Refusing to believe that, Jackson’s parents did research on their own and […]

Read More